Photo

Photo detail

Stories this photo appears in:

Allergan in $958M Deal for Migraine Drug Maker

Irvine-based drug maker Allergan Inc. said that it will buy Map Pharmaceuticals Inc. for $958 million. Allergan and Mountain View-based Map are working on Levadex, an inhalable treatment for migraine headaches.

Tease photo